14-Mar-24 |
Buy |
Mark Radcliffe |
0.000p | 5,354,015 |
£0.00 |
20-Dec-23 |
Sell |
Daniel Barton |
97.57p | 104,102 |
£101,567.64 |
20-Dec-23 |
Exercise of option |
Daniel Barton |
0.000p | 220,869 |
£0.00 |
06-Jul-23 |
Sell |
Philip Bowcock |
71.30p | 185,000 |
£131,905.00 |
06-Jul-23 |
Sell |
Philip Bowcock |
71.30p | 185,000 |
£131,905.00 |
20-Dec-23 |
Sell |
Daniel Barton |
97.57p | 104,102 |
£101,567.64 |
14-Mar-24 |
Buy |
Mark Radcliffe |
0.000p | 5,354,015 |
£0.00 |
20-Dec-23 |
Exercise of option |
Daniel Barton |
0.000p | 220,869 |
£0.00 |
Mark Radcliffe |
158,433,657 |
£121,043,314 |
Philip Bowcock |
1,259,718 |
£962,425 |
Daniel Barton |
55,490 |
£42,394 |
Damian Sanders |
25,933 |
£19,813 |
Dianne Walker |
22,154 |
£16,926 |
Neil Radcliffe |
35,592,130 |
£27,192,387 |
Kayne Anderson Rudnick Investment Management LLC |
12,914,138 |
£9,866,401 |
Martin Stewart |
10,708,031 |
£8,180,936 |
|
Final |
Interim |
Ex-Div |
08-Feb-24 |
08-Jun-23 |
Paid |
08-Mar-24 |
07-Jul-23 |
Amount |
0.95p |
0.45p |
17:08 |
14,500 @ 76.40p |
16:35 |
19,744 @ 76.40p |
16:35 |
5,569 @ 76.40p |
16:35 |
3,000 @ 76.40p |
16:35 |
150 @ 76.40p |
Chair |
Philip Bowcock |
CEO |
Mark Radcliffe |
CFO |
Daniel Barton |
Top of Page
You are here:
research